0001209191-22-029596.txt : 20220517 0001209191-22-029596.hdr.sgml : 20220517 20220517161554 ACCESSION NUMBER: 0001209191-22-029596 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220516 FILED AS OF DATE: 20220517 DATE AS OF CHANGE: 20220517 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Couling John D CENTRAL INDEX KEY: 0001894052 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-32431 FILM NUMBER: 22934701 MAIL ADDRESS: STREET 1: C/O DOLBY LABORATORIES, INC. STREET 2: 1275 MARKET STREET CITY: SAN FRANCISCO STATE: CA ZIP: 94103 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Dolby Laboratories, Inc. CENTRAL INDEX KEY: 0001308547 STANDARD INDUSTRIAL CLASSIFICATION: PATENT OWNERS & LESSORS [6794] IRS NUMBER: 900199783 STATE OF INCORPORATION: DE FISCAL YEAR END: 0927 BUSINESS ADDRESS: STREET 1: 1275 MARKET STREET CITY: SAN FRANCISCO STATE: CA ZIP: 94103 BUSINESS PHONE: 415 558 0200 MAIL ADDRESS: STREET 1: 1275 MARKET STREET CITY: SAN FRANCISCO STATE: CA ZIP: 94103 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-05-16 0 0001308547 Dolby Laboratories, Inc. DLB 0001894052 Couling John D C/O DOLBY LABORATORIES, INC. 1275 MARKET STREET SAN FRANCISCO CA 94103 0 1 0 0 SVP, Entertainment Class A Common Stock 2022-05-16 4 S 0 185 74.63 D 79235 D Shares held following the reported transactions include 35,653 restricted stock units, which are subject to forfeiture until they vest. Shares include 248 shares acquired under the Issuer's Employee Stock Purchase Plan on May 16, 2022. /s/ Daniel Rodriguez, Attorney-in-Fact for John Couling 2022-05-17